The invention is drawn to a method of using nanoparticle aggregates to form sensors and optical filters. More specifically, the present invention relates to selective 3 receptor agonists useful in the treatment of Type II diabetes and obesity. In response to determining that the first computer-design constraint is not eliminated, the first computer-design constraint is set equal to a dead-end state of the constraint. Hence, oblique parallel gaps for a primary discharge are formed between the substantially funnel-shaped inner surfaces of the upper and lower parts of the penetration hole and the two substantially conical discharging parts. Embodiments may have a torque transfer regulator, which may be operatively coupled to both stabilizer bar members.